1 a Initial esophagogastroduodenoscopy showing diffuse telangiectasias and signs of recent bleeding. b Radiofrequency ablation of the lower esophagus with a 360° Express balloon catheter. c Endoscopic follow-up after three radiofrequency ablation treatment sessions - ablation of the majority of the esophageal telangiectasias. The favorable long-term evolution suggests that RFA is a feasible, safe, and promising treatment modality for radiation esophagitis with refractory bleeding. Despite no recurrent digestive bleeding, persistent iron deficiency anemia prompted repeat esophagogastroduodenoscopies, including two RFA treatment sessions every 6 months, using a triple 12 J/cm² RFA application with a focal Halo 90 catheter. [Extracted from the article]